LLLin-Lin Li

Lin-Lin Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lin-Lin Li has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Chang-Di Xu

    Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China

    1 shared publication
  • Fan-Fan Chi

    Department of Pediatrics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China

    1 shared publication
  • Jun Hua

    Department of Emergency Medicine, Children's Hospital of Soochow University

    1 shared publication
  • Li Shen

    Department of Pharmacy, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China

    1 shared publication
  • Min Lu

    Department of Pediatrics, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China

    1 shared publication
  • Qiuyan Xu

    Department of Pediatrics, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Clinical analysis of hyperimmunoglobulin E syndrome in children with STAT3 and DOCK8 mutations in different genotypes

    by Chang-Di Xu, Fan-Fan Chi, Lin-Lin Li

    Background: Due to the nonspecific clinical manifestations of hyperimmunoglobulin E syndrome (HIES), missed or delayed diagnoses may occur, which can affect treatment efficacy and patient prognosis. This article aims to enhance early recognition and diagnosis of HIES among clinicians. Methods: We retrospectively analyzed clinical data from seven children with HIES caused by transcription-3 (STAT3) mutations treated at the Children’s Hospital of Nanjing Medical University between August 2014 and March 2021. Additionally, we reviewed relevant literature: using “hyperimmunoglobulin E syndrome” and “DOCK8 gene mutation” as search terms, 18 cases of HIES with dedicator of cytokinesis 8 (DOCK8) mutations in China were retrieved from Wanfang Data. We analyzed the clinical characteristics of these two genetic subtypes and their correlation with genetic variations. Results: The STAT3 mutation group included five males and two females, with an onset age ranging from two days to eight months. All seven cases presented with eczema and recurrent pulmonary infections; one case had liver abscesses, three had otitis media, one had cervical lymph node infection, one had cervical lymphangioma with infection, and one had infectious arthritis. Six cases showed elevated serum total immunoglobulin E (IgE) levels and peripheral blood eosinophil (EOS) counts. All children in this group had activating STAT3 mutations: one case with confirmed gene sequencing but unknown mutation site, five with de novo mutations, and one with no parental genetic testing. The DOCK8 mutation group included four males and 14 females, with an onset age ranging from half-month-old to three years. All 18 cases had eczema and recurrent pulmonary infections; six had food allergies, one had asthma, and one had autoimmune hemolysis. Serum total IgE levels were elevated in all 18 cases, and peripheral blood EOS counts were elevated in 17 cases. All children in this group had homozygous or compound heterozygous DOCK8 mutations, including large-fragment deletions, missense mutations, or frameshift mutations. Conclusions: Early in the course of HIES, clinical manifestations are often nonspecific. HIES should be considered in patients with recurrent eczema, skin abscesses, and pulmonary infections—especially when combined with facial or skeletal abnormalities. Early recognition facilitates timely treatment, and genetic testing can aid in early diagnosis.

  • Open Access

    Establishment and validation of a prediction model for apnea on bronchiolitis

    by Qiuyan Xu, Li Shen, Min Lu, Shuangqin Ran, Wujun Jiang, Jun Hua, Linlin Li

    Objective: The objective of this study is to examine the risk factors associated with apnea in hospitalized patients diagnosed with bronchiolitis and to develop a nomogram prediction model for the early identification of patients who are at risk of developing apnea.Methods: The clinical data of patients diagnosed with acute bronchiolitis and hospitalized at the Children's Hospital of Nanjing Medical University between February 2018 and May 2021 were retrospectively analyzed. LASSO regression and logistic regression analysis were used to determine the risk factors for apnea in these patients. A nomogram was constructed based on variables selected through multivariable logistic regression analysis. Receiver operating characteristic (ROC) curve and calibration curve were used to assess the accuracy and discriminative ability of the nomogram model, and decision curve analysis (DCA) was performed to evaluate the model's performance and clinical effectiveness.Results: A retrospective analysis was conducted on 613 children hospitalized with bronchiolitis, among whom 53 (8.6%) experienced apnea. The results of Lasso regression and Logistic regression analyses showed that underlying diseases, feeding difficulties, tachypnea, WBC count, and lung consolidation were independent risk factors for apnea. A nomogram prediction model was constructed based on the five predictors mentioned above. After internal validation, the nomogram model demonstrated an AUC of 0.969 (95% CI 0.951–0.987), indicating strong predictive performance for apnea in bronchiolitis. Calibration curve analysis confirmed that the nomogram prediction model had good calibration, and the clinical decision curve analysis (DCA) indicated that the nomogram was clinically useful in estimating the net benefit to patients.Conclusion: In this study, a nomogram model was developed to predict the risk of apnea in hospitalized children with bronchiolitis. The model showed good predictive performance and clinical applicability, allowing for timely identification and intensified monitoring and treatment of high-risk patients to improve overall clinical prognosis.